Vaccines that prevent smallpox and mpox come in two varieties. One uses a single shot of a live virus but carries the risk of ...

However, the immune correlates of protection against smallpox are poorly understood. Knowledge of the correlates of protection will be useful in facilitating the development of new smallpox vaccines.

A version of a smallpox vaccine was developed in 1796, and in 1959 global health experts decided to pursue full eradication. In the decade that followed, it became clear that such an ambitious ...

New construction at a military research site near Moscow reveals a specialized laboratory complex designed to research and handle deadly pathogens, experts say.

Press Release - A drug currently approved for smallpox in the U.S. will undergo clinical trials to treat patients infected by the Mpox viruswho are at risk of severe complications in the Democratic ...

as part of BioFactura's prime contract valued at up to $78 million for the advanced development of a Smallpox Biodefense Therapeutic. This monoclonal antibody cocktail therapeutic has the potential to ...

The Frederick biotechnology company BioFactura has announced $7.8 million in new contract activations to study a treatment for a potential smallpox outbreak. The company has gotten contract option ...

The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.

Tonix is advancing TNX-801's development with FDA feedback, collaborations for large-scale manufacturing, and planned clinical trials in Kenya, believing its vaccine could offer broad, long-lasting ...

WHO’S SHOWING UP EARLY? Trump had better hope that his—ah— unorthodox appeal to female voters is paying off. Politico reports ...

South Korea’s first anthrax vaccine could soon be approved amid growing security concerns over thousands of rubbish-filled ...

An infection with the latest mpox variant, clade 1b, has been detected in the United Kingdom for the first time, the UK ...